FDA says new rules should increase competition for insulin, but others aren't as sure

The Food and Drug Administration's new guidance should create a clear path for generic makers of insulin to enter the market. But some say it will do little to reverse its rising costs.

from modernhealthcare

If You Enjoyed This, Take 5 Seconds To Share It

• 
• 
• 
• 
• 
•